RCPCMi007-A-1

IPSFF1S deltab2m

General

Cell Line

hPSCreg name RCPCMi007-A-1
Cite as:
RCPCMi007-A-1 (RRID:CVCL_A8DK)
Alternative name(s)
IPSFF1S deltab2m
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
RCPCMi007-A
(IPSFF1S)
MUSIi001-A-1
(B2M-KO-SFiPSC5, HLA-I-null SFiPSCs)
DHMi005-A-8
(L Delta B2M Clone 6)
IRFMNi001-B-2
(CIone M CIITAKO-B2MKO)
DHMi005-A-9
(L Delta B2M Clone 11)
CHAHESe001-A-1
(CHA-hES NT6 B2M KO#67)
Donor diseases:
age-related macular degeneration
Last update 5th July 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)

External Databases

BioSamples SAMEA8944453
Cellosaurus CVCL_A8DK
Wikidata Q107116727

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: allowed
Subclone of

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

External Databases (Donor)

BioSamples SAMEA8944452

Ethics

Also have a look at the ethics information for the parental line RCPCMi007-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

The source cell information can be found in the parental cell line RCPCMi007-A.

Reprogramming method

Vector type None

Vector free reprogramming

Other

Selection criteria for clones cloning on Tesr1 media for 4-5 passages. the main selection criterion morphology and stable karyotype
Derived under xeno-free conditions
Yes
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzymatically
TrypLE
CO2 Concentration 5 %
Medium TeSR™ E8™
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
DPPA-5
Yes
NANOG
Yes
SALL-4
Yes
SOX2
Yes
SSEA-4
Yes
TRA 1-81
Yes
POU5F1 (OCT-4)
Yes
Score:
Marker Present Absent
mCpG
OCT4
Morphology pictures
фазовый контраст.tif
phase contrast microscopy
Differentiation Potency
Hepatocyte
Ont Id: CL_0000182
In vitro spontaneous differentiation
Endothelial Cell
Ont Id: NCIT_C12865
In vitro directed differentiation
Marker Expressed
CD31
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
CK18 (keratin 18)
Unknown

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX
Passage number: 13
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
B2M beta-2-microglobulin (target)
Gene knock-out
Chr 15: 44.71 – 44.72 Mb
CRISPR-associated (CRISPR/Cas) System
seq.jpg
Deletion part of deltab2m gene